Sylogist Change To Operating Activities vs Change To Account Receivables Analysis

SYZ Stock

CAD 10.00 0.01 0.10%

Sylogist financial indicator trend analysis is much more than just breaking down Sylogist prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Sylogist is a good investment. Please check the relationship between Sylogist Change To Operating Activities and its Change To Account Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sylogist. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Change To Operating Activities vs Change To Account Receivables

Change To Operating Activities vs Change To Account Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Sylogist Change To Operating Activities account and Change To Account Receivables. At this time, the significance of the direction appears to have strong relationship.

The correlation between Sylogist's Change To Operating Activities and Change To Account Receivables is 0.79. Overlapping area represents the amount of variation of Change To Operating Activities that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of Sylogist, assuming nothing else is changed. The correlation between historical values of Sylogist's Change To Operating Activities and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Operating Activities of Sylogist are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of Change To Operating Activities i.e., Sylogist's Change To Operating Activities and Change To Account Receivables go up and down completely randomly.

Correlation Coefficient

0.79

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Change To Operating Activities

Change To Account Receivables

Most indicators from Sylogist's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Sylogist current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sylogist. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Sylogist's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 26th of November 2024, Enterprise Value is likely to grow to about 191.7 M, while Selling General Administrative is likely to drop about 8.7 M.

	2021	2022	2023	2024 (projected)
Total Revenue	38.7M	69M	65.5M	68.8M
Depreciation And Amortization	6.8M	12.9M	10.1M	10.7M

Total Revenue Depreciation And Amortization

Sylogist fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Inventory	Intangible Assets	Current Deferred Revenue	Short Term Investments	Non Currrent Assets Other	Good Will
Total Assets		0.7	0.79	0.85	0.71	0.74	-0.04	-0.83	0.58	0.47	0.89	0.45	0.65	0.59	0.88	0.91	-0.38	0.86	0.6	0.72	0.12	0.89	0.91	0.22	-0.54	0.84
Short Long Term Debt Total	0.7		0.77	0.95	0.03	0.97	0.66	-0.85	0.56	-0.25	0.93	-0.27	0.75	0.17	0.93	0.7	-0.17	0.96	-0.12	1.0	0.08	0.94	0.85	-0.06	-0.51	0.96
Other Current Liab	0.79	0.77		0.86	0.29	0.81	0.39	-0.73	0.85	-0.03	0.9	-0.05	0.89	0.31	0.88	0.91	-0.25	0.87	0.12	0.76	0.08	0.87	0.8	0.01	-0.21	0.87
Total Current Liabilities	0.85	0.95	0.86		0.25	0.94	0.47	-0.93	0.65	-0.03	0.98	-0.05	0.84	0.31	0.95	0.86	-0.26	1.0	0.11	0.96	0.11	0.98	0.96	0.01	-0.47	1.0
Total Stockholder Equity	0.71	0.03	0.29	0.25		0.12	-0.7	-0.31	0.17	0.91	0.33	0.9	0.06	0.72	0.34	0.5	-0.36	0.27	0.97	0.05	0.08	0.33	0.41	0.5	-0.42	0.22
Property Plant And Equipment Net	0.74	0.97	0.81	0.94	0.12		0.59	-0.84	0.59	-0.17	0.94	-0.19	0.74	0.21	0.94	0.73	-0.21	0.95	-0.04	0.96	0.05	0.94	0.84	-0.05	-0.54	0.95
Net Debt	-0.04	0.66	0.39	0.47	-0.7	0.59		-0.34	0.34	-0.89	0.41	-0.89	0.54	-0.36	0.4	0.16	0.19	0.46	-0.81	0.63	-0.04	0.4	0.26	-0.32	-0.02	0.5
Retained Earnings	-0.83	-0.85	-0.73	-0.93	-0.31	-0.84	-0.34		-0.51	-0.08	-0.9	-0.05	-0.79	-0.37	-0.84	-0.83	0.26	-0.92	-0.21	-0.86	-0.02	-0.91	-0.96	-0.07	0.53	-0.93
Accounts Payable	0.58	0.56	0.85	0.65	0.17	0.59	0.34	-0.51		-0.08	0.69	-0.11	0.78	-0.02	0.68	0.81	-0.39	0.66	0.04	0.55	0.1	0.66	0.57	-0.2	-0.02	0.66
Cash	0.47	-0.25	-0.03	-0.03	0.91	-0.17	-0.89	-0.08	-0.08		0.03	0.99	-0.22	0.55	0.04	0.23	-0.34	-0.02	0.97	-0.22	0.1	0.04	0.17	0.33	-0.25	-0.07
Non Current Assets Total	0.89	0.93	0.9	0.98	0.33	0.94	0.41	-0.9	0.69	0.03		0.01	0.82	0.36	0.98	0.89	-0.29	0.99	0.17	0.94	0.1	1.0	0.94	0.05	-0.51	0.99
Cash And Short Term Investments	0.45	-0.27	-0.05	-0.05	0.9	-0.19	-0.89	-0.05	-0.11	0.99	0.01		-0.24	0.56	0.02	0.21	-0.29	-0.04	0.97	-0.24	0.08	0.02	0.15	0.34	-0.23	-0.09
Net Receivables	0.65	0.75	0.89	0.84	0.06	0.74	0.54	-0.79	0.78	-0.22	0.82	-0.24		0.2	0.74	0.87	-0.1	0.83	-0.06	0.75	0.01	0.79	0.81	-0.07	-0.12	0.85
Common Stock Shares Outstanding	0.59	0.17	0.31	0.31	0.72	0.21	-0.36	-0.37	-0.02	0.55	0.36	0.56	0.2		0.33	0.43	0.11	0.32	0.66	0.18	0.1	0.35	0.42	0.8	-0.41	0.28
Non Current Liabilities Total	0.88	0.93	0.88	0.95	0.34	0.94	0.4	-0.84	0.68	0.04	0.98	0.02	0.74	0.33		0.85	-0.31	0.97	0.17	0.92	0.06	0.98	0.88	0.04	-0.55	0.96
Other Current Assets	0.91	0.7	0.91	0.86	0.5	0.73	0.16	-0.83	0.81	0.23	0.89	0.21	0.87	0.43	0.85		-0.3	0.87	0.38	0.71	0.02	0.88	0.89	0.07	-0.33	0.86
Other Stockholder Equity	-0.38	-0.17	-0.25	-0.26	-0.36	-0.21	0.19	0.26	-0.39	-0.34	-0.29	-0.29	-0.1	0.11	-0.31	-0.3		-0.27	-0.32	-0.18	-0.62	-0.31	-0.3	0.16	0.19	-0.24
Total Liab	0.86	0.96	0.87	1.0	0.27	0.95	0.46	-0.92	0.66	-0.02	0.99	-0.04	0.83	0.32	0.97	0.87	-0.27		0.12	0.96	0.1	0.99	0.95	0.01	-0.49	1.0
Total Current Assets	0.6	-0.12	0.12	0.11	0.97	-0.04	-0.81	-0.21	0.04	0.97	0.17	0.97	-0.06	0.66	0.17	0.38	-0.32	0.12		-0.09	0.08	0.18	0.31	0.45	-0.32	0.08
Short Term Debt	0.72	1.0	0.76	0.96	0.05	0.96	0.63	-0.86	0.55	-0.22	0.94	-0.24	0.75	0.18	0.92	0.71	-0.18	0.96	-0.09		0.1	0.94	0.86	-0.06	-0.51	0.96
Inventory	0.12	0.08	0.08	0.11	0.08	0.05	-0.04	-0.02	0.1	0.1	0.1	0.08	0.01	0.1	0.06	0.02	-0.62	0.1	0.08	0.1		0.09	0.12	0.1	0.06	0.06
Intangible Assets	0.89	0.94	0.87	0.98	0.33	0.94	0.4	-0.91	0.66	0.04	1.0	0.02	0.79	0.35	0.98	0.88	-0.31	0.99	0.18	0.94	0.09		0.94	0.04	-0.54	0.98
Current Deferred Revenue	0.91	0.85	0.8	0.96	0.41	0.84	0.26	-0.96	0.57	0.17	0.94	0.15	0.81	0.42	0.88	0.89	-0.3	0.95	0.31	0.86	0.12	0.94		0.08	-0.47	0.95
Short Term Investments	0.22	-0.06	0.01	0.01	0.5	-0.05	-0.32	-0.07	-0.2	0.33	0.05	0.34	-0.07	0.8	0.04	0.07	0.16	0.01	0.45	-0.06	0.1	0.04	0.08		-0.25	-0.02
Non Currrent Assets Other	-0.54	-0.51	-0.21	-0.47	-0.42	-0.54	-0.02	0.53	-0.02	-0.25	-0.51	-0.23	-0.12	-0.41	-0.55	-0.33	0.19	-0.49	-0.32	-0.51	0.06	-0.54	-0.47	-0.25		-0.46
Good Will	0.84	0.96	0.87	1.0	0.22	0.95	0.5	-0.93	0.66	-0.07	0.99	-0.09	0.85	0.28	0.96	0.86	-0.24	1.0	0.08	0.96	0.06	0.98	0.95	-0.02	-0.46

Click cells to compare fundamentals

Sylogist Account Relationship Matchups

Sylogist fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	78.2M	71.0M	98.0M	103.1M	96.6M	101.4M
Other Current Liab	180K	2.2M	3.2M	5.6M	6.4M	6.7M
Total Current Liabilities	17.3M	16.6M	39.8M	50.9M	48.7M	51.2M
Total Stockholder Equity	58.5M	51.9M	46.7M	39.9M	37.6M	26.3M
Property Plant And Equipment Net	141K	573K	1.6M	1.7M	1.4M	1.5M
Net Debt	(53.1M)	(42.3M)	(10.6M)	7.4M	6.1M	6.4M
Retained Earnings	(23.1M)	(31.7M)	(40.1M)	(50.0M)	(50.7M)	(48.2M)
Accounts Payable	555K	372K	630K	1.6M	1.9M	2.0M
Cash	53.1M	42.8M	29.6M	14.5M	11.6M	17.3M
Non Current Assets Total	21.6M	22.8M	64.5M	75.6M	70.3M	73.8M
Cash And Short Term Investments	53.1M	42.8M	29.6M	14.5M	11.6M	18.3M
Net Receivables	1.5M	3.5M	2.0M	9.4M	10.9M	11.4M
Common Stock Shares Outstanding	23.0M	23.8M	24.1M	23.9M	23.7M	17.8M
Liabilities And Stockholders Equity	78.2M	71.0M	98.0M	103.1M	96.6M	101.4M
Non Current Liabilities Total	2.4M	2.4M	11.6M	12.2M	10.3M	10.8M
Other Stockholder Equity	2.4M	3.3M	4.5M	5.5M	5.8M	6.3M
Total Liab	19.7M	19.1M	51.3M	63.2M	59.0M	61.9M
Total Current Assets	56.6M	48.1M	33.6M	27.5M	26.3M	21.8M
Short Term Debt	2.3M	380K	18.5M	21.5M	17.5M	18.4M
Accumulated Other Comprehensive Income	559K	722K	(32K)	2.2M	1.5M	1.6M
Inventory	381K	267K	218K	211K	248K	225.6K
Intangible Assets	14.3M	14.1M	41.6M	47.4M	42.7M	44.8M
Current Deferred Revenue	14.3M	13.7M	17.5M	22.2M	22.9M	24.1M
Common Stock	78.7M	79.6M	82.4M	82.2M	81.0M	72.0M
Capital Surpluse	2.4M	3.3M	4.5M	5.5M	4.9M	4.7M
Property Plant Equipment	141K	573K	1.6M	1.8M	2.0M	2.1M
Other Liab	2.4M	2.3M	11.0M	13.8M	15.8M	16.6M
Net Tangible Assets	37.0M	29.6M	(16.2M)	(38.6M)	(34.8M)	(33.0M)
Net Invested Capital	58.5M	51.9M	64.9M	54.8M	63.0M	57.6M
Net Working Capital	39.2M	31.5M	(6.2M)	(22.4M)	(20.2M)	(19.2M)

Pair Trading with Sylogist

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sylogist position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sylogist will appreciate offsetting losses from the drop in the long position's value.

Moving against Sylogist Stock

0.38

CTF-UN

Citadel Income

Pair Corr

The ability to find closely correlated positions to Sylogist could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sylogist when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sylogist - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sylogist to buy it.

The correlation of Sylogist is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sylogist moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sylogist moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Sylogist can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Other Information on Investing in Sylogist Stock

Balance Sheet is a snapshot of the financial position of Sylogist at a specified time, usually calculated after every quarter, six months, or one year. Sylogist Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Sylogist and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Sylogist currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sylogist Change To Operating Activities vs Change To Account Receivables Analysis

Change To Operating Activities vs Change To Account Receivables

Change To Operating Activities vs Change To Account Receivables Correlation Analysis

Correlation Coefficient

Change To Operating Activities

Change To Account Receivables

Sylogist fundamental ratios Correlations

Sylogist Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sylogist fundamental ratios Accounts

Pair Trading with Sylogist

Moving against Sylogist Stock

Other Information on Investing in Sylogist Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Total Current Liabilities
Good Will	+ 1.0	Total Current Liabilities
Intangible Assets	+ 1.0	Non Current Assets Total
Good Will	+ 1.0	Total Liab
Cash And Short Term Investments	+ 0.99	Cash

Current Deferred Revenue	- 0.96	Retained Earnings
Good Will	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Total Current Liabilities
Total Liab	- 0.92	Retained Earnings
Intangible Assets	- 0.91	Retained Earnings
Non Current Assets Total	- 0.9	Retained Earnings